© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Equity IPOs

Top Section/Ad

Top Section/Ad

Most recent


SMG’s drop below offer price sends mixed signals
SMG pares back gains after year’s largest IPO, Verisure to follow
Italy’s top independent investment bank must try to survive inside Monte dei Paschi
There are two IPO markets — and the boring one is best
More articles/Ad

More articles/Ad

More articles

  • Joinn Laboratories has sealed its HK$6.54bn ($843.8m) listing at the top of the price range, tapping into Hong Kong’s IPO market as demand hits fever pitch, according to a source familiar with the matter.
  • Cint, a digital market research company, has priced a Skr5.96bn ($720m) IPO on Nasdaq Stockholm, the largest new listing on the exchange this year.
  • Lakestar Spac I, a new special purpose acquisition company backed by German venture capitalist Klaus Hommels, has priced its IPO on the Frankfurt Stock Exchange, raising €275m.
  • SciClone Pharmaceuticals, which manufactures a possible treatment for the coronavirus, hit the IPO market with a HK$2.18bn ($281.2m) offering on Friday.
  • HSBC chooses chief sustainability officer — JP Morgan creates European unit for Spacs — Piero Novelli to quit UBS
  • South Korean e-commerce firm Coupang is set for a multi-billion-dollar New York IPO — the first US listing from the country for a decade. The deal structure could appeal to other Korean start-ups, bankers said this week. Jonathan Breen reports.